Bodla, Z.H.; Hashmi, M.; Niaz, F.; Auyeung, A.B.; Oyetoran, A.; Khalil, M.J.; Faisal, M.S.; Khalid, F.; Zakieh, A.-R.; Bazikian, Y.;
et al. Double Trouble: COVID-19 Infection Exacerbates Sickle Cell Crisis Outcomes in Hospitalized Patients—Insights from National Inpatient Sample 2020. Hematol. Rep. 2024, 16, 421-430.
https://doi.org/10.3390/hematolrep16030041
AMA Style
Bodla ZH, Hashmi M, Niaz F, Auyeung AB, Oyetoran A, Khalil MJ, Faisal MS, Khalid F, Zakieh A-R, Bazikian Y,
et al. Double Trouble: COVID-19 Infection Exacerbates Sickle Cell Crisis Outcomes in Hospitalized Patients—Insights from National Inpatient Sample 2020. Hematology Reports. 2024; 16(3):421-430.
https://doi.org/10.3390/hematolrep16030041
Chicago/Turabian Style
Bodla, Zubair Hassan, Mariam Hashmi, Fatima Niaz, Austin B. Auyeung, Anuoluwa Oyetoran, Muhammad Jahanzeb Khalil, Muhammad Salman Faisal, Farhan Khalid, Abdel-Rahman Zakieh, Yvette Bazikian,
and et al. 2024. "Double Trouble: COVID-19 Infection Exacerbates Sickle Cell Crisis Outcomes in Hospitalized Patients—Insights from National Inpatient Sample 2020" Hematology Reports 16, no. 3: 421-430.
https://doi.org/10.3390/hematolrep16030041
APA Style
Bodla, Z. H., Hashmi, M., Niaz, F., Auyeung, A. B., Oyetoran, A., Khalil, M. J., Faisal, M. S., Khalid, F., Zakieh, A.-R., Bazikian, Y., & Bray, C. L.
(2024). Double Trouble: COVID-19 Infection Exacerbates Sickle Cell Crisis Outcomes in Hospitalized Patients—Insights from National Inpatient Sample 2020. Hematology Reports, 16(3), 421-430.
https://doi.org/10.3390/hematolrep16030041
